Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Vakzine Projekt Management GmbH
DescriptionMultivalent vaccine against human cytomegalovirus (HCMV) containing defective HCMV particles or dense bodies (DB)
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationCytomegalovirus (CMV)
Indication DetailsPrevent cytomegalovirus (CMV) infections after transplant and pregnancy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today